Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)

Published:2020-06 Issue:2 Volume:5 Page:274-284
ISSN:2470-9239
Container-title:Epilepsia Open
language:en
Short-container-title:Epilepsia Open

Author:

Yamamoto Takamichi¹^ORCID,Lim Sung Chul²^ORCID,Ninomiya Hirotomo³^ORCID,Kubota Yuichi⁴^ORCID,Shin Won Chul⁵^ORCID,Kim Dong Wook⁶^ORCID,Shin Dong Jin⁷^ORCID,Hoshida Tohru⁸,Iida Koji⁹,Ochiai Taku¹⁰^ORCID,Matsunaga Risa¹¹^ORCID,Higashiyama Hiroyuki¹²,Hiramatsu Hidetaka¹¹,Kim Ji Hyun¹³^ORCID

Affiliation:

1. Seirei Hamamatsu General Hospital Hamamatsu Japan

2. The Catholic University of KoreaSt. Vincent Hospital Gyeonggi‐do Republic of Korea

3. Itami City Hospital Hyogo Japan

4. TMG Asaka Medical Center Saitama Japan

5. Kyung Hee University Hospital at Gangdong Seoul Republic of Korea

6. Konkuk University School of Medicine Seoul Republic of Korea

7. Gachon University Gil Medical Center Incheon Republic of Korea

8. National Hospital Organization Nara Medical Center Nara Japan

9. Hiroshima University Hiroshima Japan

10. Ochiai Neurological Clinic Saitama Japan

11. Eisai Co., Ltd. Tokyo Japan

12. Formerly: Eisai Co., Ltd. Tokyo Japan

13. Korea University Guro Hospital Seoul Republic of Korea

Funder

Eisai

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/epi4.12398

Reference32 articles.

1. Early Identification of Refractory Epilepsy

2. Levetiracetam monotherapy for newly diagnosed epilepsy patients

3. Efficacy and safety of levetiracetam and carbamazepine as monotherapy in partial seizures;Suresh SH;Epilepsy Res Treat,2015

4. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial

5. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: Results of a phase III, randomized, double-blind study

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of CYP3A4 genetic polymorphisms on the pharmacokinetics and efficacy of perampanel in Chinese pediatric patients with epilepsy;Seizure: European Journal of Epilepsy;2024-08

2. Perampanel for the treatment of Asian people with epilepsy: Real-world evidence from the PERMIT extension study;Journal of the Neurological Sciences;2024-08

3. Serum perampanel levels in patients with seizures are not affected by hemodialysis;Epilepsia Open;2024-06-24

4. Effects of CYP3A5*3 genetic polymorphisms on the pharmacokinetics of perampanel in Chinese pediatric patients with epilepsy;Pharmacogenetics and Genomics;2024-05-13

5. Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study;Journal of Neurology;2024-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3